Memorial Sloan Kettering Cancer Center 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy 2019
Format:33 videos + 30 pdfs, size: 10.5 GB
Course Audience: hematologist, physicians, researchers, fellows, advanced practice providers, who provide care for patients undergoing HCT
Overview:
Date & LocationFriday, October 11, 2019, 7:00 AM – Saturday, October 12, 2019, 1:00 PM EST, Zuckerman Research Center, 417 East 68th Street, New York , NY
SpecialtiesSpecialties – Bone Marrow Transplant, Cardiology, Cellular Therapeutics, Gastroenterology, Infectious Diseases, Laboratory Medicine, Medical Oncology, Nephrology, Neurology, Oncology and HematologyOverviewToday, more than 10,000 hematopoietic cell transplantations (HCTs) are performed yearly in the United States as treatment for more than 70 life threatening illnesses including cancers, genetic disorders, and other diseases. Also, given the shift toward cellular therapies in the field of HCT, the number of patients treated with these novel biologic agents is rapidly increasing.
Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, this symposium will bring together experts and thought leaders from around the world in the fields of HCT, cellular therapies, and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT and cellular therapies, current advances in the field, and best practices to both prevent and treat these toxicities and symptoms.
The target audience for this symposium includes physicians, researchers, fellows, advanced practice providers, nurses, pharmacists, data managers and other healthcare professionals who provide care for patients undergoing HCT and cellular therapies.
We are pleased to offer a live simulcast option for the 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy. CME credit is offered for the live simulcast and active participation is required throughout the course. We do hope you will attend in person but understand that can sometimes be a challenge so we are happy to offer the live simulcast as an option. Registration for the simulcast is required; to register, please select the “Live Simulcast” option during course registration.
The 2nd International Symposium on Biology, Prevention, and Treatment of Toxicities After Transplantation and Cellular Therapy invites the submission of abstracts. Abstracts for the poster session will be selected on the basis of scientific merit and content quality. Abstract submission is open to all, and we also highly encourage fellows, residents, pharmacists, and advanced practice providers to submit relevant abstracts in the area of biology, prevention, and treatment of toxicities after transplantation and cellular therapy. In addition, abstracts related to trials and/or clinical research in progress will be accepted. Top awarded abstracts will receive a travel grant tied to attending this symposium. To submit an abstract, please select the ‘Abstract’ button above.
Objectives- Understand the mechanisms of the most common treatment-related toxicities after HCT and cellular therapy.
- Identify best practices to prevent and treat toxicities and symptom burden after HCT and cellular therapy to improve the patient experience and reduce non-relapse mortality.
- Understand how to approach prevention and treatment of toxicities and symptom burden in unique HCT and cellular therapy patient populations.
Accelerated Functional Aging and Sarcopenia After HCT (Video MP4 Format)
Accelerated Functional Aging and Sarcopenia After HCT (PDF Format)Are CAR T Cells and Novel Cellular Therapies Cost-effective. (Video MP4 Format)Are CAR T Cells and Novel Cellular Therapies Cost-effective. (PDF Format)Association of Patient and Donor Clonal Hematopoiesis with HCT Toxicities (Video MP4 Format)Association of Patient and Donor Clonal Hematopoiesis with HCT Toxicities (PDF Format)Association of the Pulmonary Virioma and Post-HCT Pulmonary Toxicities (Video MP4 Format)Association of the Pulmonary Virioma and Post-HCT Pulmonary Toxicities (PDF Format)Choosing Wisely in HCT and Its Applicability to Novel Cellular Therapies (Video MP4 Format)Choosing Wisely in HCT and Its Applicability to Novel Cellular Therapies (PDF Format)Chronic Disease Burden in Survivors of Childhood HCT (Video MP4 Format)Chronic Disease Burden in Survivors of Childhood HCT (PDF Format)Emerging Evidence on the Pathobiology and Biomarkers of Regimen-Related Mucosal Injury (Video MP4 Format)Emerging Evidence on the Pathobiology and Biomarkers of Regimen-Related Mucosal Injury (PDF Format)EN v. PN – Nutritional Supplementation Early After HCT – Enteral or Parenteral (Video MP4 Format)EN v. PN – Nutritional Supplementation Early After HCT – Enteral or Parenteral (PDF Format)End-of-Life Care in HCT- What Do HCT Physicians Think About Palliative Care. (Video MP4 Format)End-of-Life Care in HCT- What Do HCT Physicians Think About Palliative Care. (PDF Format)GI and Hepatobiliary Complications of HCT (Video MP4 Format)GI and Hepatobiliary Complications of HCT (PDF Format)Harmonizing Conditioning Regimens – How PK PD Impacts Toxicities and Outcomes (Video MP4 Format)Harmonizing Conditioning Regimens – How PK PD Impacts Toxicities and Outcomes (PDF Format)Harmonizing VOD SOS Diagnosis and Classification (Video MP4 Format)Harmonizing VOD SOS Diagnosis and Classification (PDF Format)Harnessing Technology, Big Data, and PROs to Reduce Toxicities and Symptoms After HCT and Cellular Therapy (Video MP4 Format)Harnessing Technology, Big Data, and PROs to Reduce Toxicities and Symptoms After HCT and Cellular Therapy (PDF Format)Human Microbiome in Hematopoiesis and Immune Recovery After HCT and Cellular Therapies (Video MP4 Format)Human Microbiome in Hematopoiesis and Immune Recovery After HCT and Cellular Therapies (PDF Format)Importance of Standardizing Cause-specific Death Adjudication After HCT and Cellular Therapies (Video MP4 Format)Importance of Standardizing Cause-specific Death Adjudication After HCT and Cellular Therapies (PDF Format)Incorporating Biomarkers of Non-GVHD Toxicity in Clinical Trial Design (Video MP4 Format)Incorporating Biomarkers of Non-GVHD Toxicity in Clinical Trial Design (PDF Format)Lunch Breakout (105)- Endothelial Activation and Stress Index (EASIX) results predicts outcomes in unmodified and CD34-selected grafts (Video MP4 Format)Lunch Breakout (105)- Endothelial Activation and Stress Index (EASIX) results predicts outcomes in unmodified and CD34-selected grafts (PDF Format)Lunch Breakout (136)- Harnessing Telemedicine Potential in HCT and Cellular Therapies (Video MP4 Format)Lunch Breakout (136)- Harnessing Telemedicine Potential in HCT and Cellular Therapies (PDF Format)Lunch Breakout (136)t- HCT Telehealth Care- Can you Hear Me Now. (Video MP4 Format)Lunch Breakout (136)t- HCT Telehealth Care- Can you Hear Me Now (PDF Format)Mechanisms of Gastrointestinal Injury in HCT – Learning from IBD (Video MP4 Format)Mechanisms of Gastrointestinal Injury in HCT – Learning from IBD (PDF Format)Novel Biomarkers of Acute and Chronic Renal Injury After HCT and Cellular Therapies (Video MP4 Format)Novel Biomarkers of Acute and Chronic Renal Injury After HCT and Cellular Therapies (PDF Format)Patient-Reported Outcomes and Symptom Burden After CAR T Cell Therapy (Video MP4 Format)Patient-Reported Outcomes and Symptom Burden After CAR T Cell Therapy (PDF Format)Preventing All-Cause Death after HCT – What Should be our Focus when Designing Trials (Video MP4 Format)Preventing All-Cause Death after HCT – What Should be our Focus when Designing Trials (PDF Format)Q&A with Speakers I (Video MP4 Format)Q&A with Speakers II (Video MP4 Format)Q&A with Speakers III (Video MP4 Format)Q&A with Speakers Networking Reception & Poster (Video MP4 Format)Q&A with Speakers (Video MP4 Format)Strategies to Improve Immune Reconstitution After HCT and Novel Cellular Therapie (Video MP4 Format)Strategies to Improve Immune Reconstitution After HCT and Novel Cellular Therapie (PDF Format)The Injured Endothelium in HCT Toxicities (PDF Format)The Injured Endothelium in HCT ToxicitiesThe Injured Endothelium in HCT Toxicities (Video MP4 Format)The Short and Long-Term Costs of Critical Illness After HCT and Cellular Therapies (Video MP4 Format)The Short and Long-Term Costs of Critical Illness After HCT and Cellular Therapies (PDF Format)Toxicities and Outcomes in the Geriatric Patient After HCT and Cellular Therapies (Video MP4 Format)Toxicities and Outcomes in the Geriatric Patient After HCT and Cellular Therapies (PDF Format)Toxicities_2019_Brochure2 (PDF Format)Virus specific T cells to Mitigate Infectious Complications After HCT (Video MP4 Format)Virus specific T cells to Mitigate Infectious Complications After HCT (PDF Format)Welcome, Opening Remarks and Conference Overview (PDF Format)